Publication:
Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak

Simple item page
dc.contributor.authorKARADAĞ SAYGI, NAİME EVRİM
dc.contributor.authorsYalcinkaya, Ebru Yilmaz; Karadag Saygi, Evrim; Ozyemisci Taskiran, Ozden; Capan, Nalan; Kutlay, Sehim; Sonel Tur, Birkan; Ozlem, E. L.; Unlu Akyuz, Ece; Tekin, Suda; Ofluoglu, Demet; Zinnuroglu, Murat; Akpinar, Pinar; Ozekli Misirlioglu, Tugce; Huner, Berrin; Nur, Hakan; Caglar, Sibel; Sezgin, Melek; Tikiz, Canan; Ones, Kadriye; Icagasioglu, Afitap; Aydin, Resa
dc.date.accessioned2022-03-10T11:39:55Z
dc.date.available2022-03-10T11:39:55Z
dc.description.abstractSpasticity is the most common motor disturbance in cerebral palsy (CP). Lockdown in the COVID-19 outbreak has profoundly changed daily routines, and similarly caused the suspension of spasticity treatment plans. Besides, the delay in botulinum toxin (BoNT) injection, which is important in the management of focal spasticity, led to some problems in children. This consensus report includes BoNT injection recommendations in the management of spasticity during the COVID-19 pandemic in children with CP. In order to develop the consensus report, physical medicine and rehabilitation (PMR) specialists experienced in the field of pediatric rehabilitation and BoNT injections were invited by Pediatric Rehabilitation Association. Items were prepared and adapted to the Delphi technique by PMR specialists. Then they were asked to the physicians experienced in BoNT injections (PMR specialist, pediatric orthopedists, and pediatric neurologists) or COVID-19 (pediatric infectious disease, adult infectious disease). In conclusion, the experts agree that conservative management approaches for spasticity may be the initial steps before BoNT injections. BoNT injections can be administered to children with CP with appropriate indications and with necessary precautions during the pandemic.
dc.identifier.doi10.3906/sag-2009-5
dc.identifier.eissn1303-6165
dc.identifier.issn1300-0144
dc.identifier.pubmed33350298
dc.identifier.urihttps://hdl.handle.net/11424/219935
dc.identifier.wosWOS:000646281600001
dc.language.isoeng
dc.publisherTUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY
dc.relation.ispartofTURKISH JOURNAL OF MEDICAL SCIENCES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBotulinum toxin
dc.subjectcerebral palsy
dc.subjectCOVID-19
dc.subjectpandemic
dc.subjectspasticity
dc.subjectADVERSE EVENTS
dc.subjectGUIDANCE
dc.titleConsensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak
dc.typereview
dspace.entity.typePublication
local.avesis.id9006b3a1-d84f-46b7-bd49-3093739c5353
local.import.packageSS4
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.indexed.atTRDIZIN
local.journal.numberofpages8
oaire.citation.endPage392
oaire.citation.issue2
oaire.citation.startPage385
oaire.citation.titleTURKISH JOURNAL OF MEDICAL SCIENCES
oaire.citation.volume51
relation.isAuthorOfPublication5ac4517a-f739-4f83-b6fc-a6f81630bca8
relation.isAuthorOfPublication.latestForDiscovery5ac4517a-f739-4f83-b6fc-a6f81630bca8

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
sag-51-2-1-2009-5.pdf
Size:
145.44 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs